Oct 15, 2024, 10:18 AM by

PHARMASEAL specializes in state-of-the-art trial management software for life sciences (unified CTMS/eTMF) and LEDGER RUN, INC., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting, contracts and payments, announced their partnership today. Through the partnership, PHARMASEAL’S Engility® Platform software Engility CTMS, Engility eTMF and LEDGER RUN'S unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.

Oct 15, 2024, 10:18 AM by

Sapio Sciences, the science-aware™ lab informatics platform, today announced the addition of new immunogenicity bioanalysis features to its industry-leading lab informatics platform. These new capabilities in the Sapio LIMS (Laboratory Information Management System) and Sapio ELN (Electronic Lab Notebook) solutions streamline testing workflows for detecting anti-drug antibodies (ADA) and neutralizing antibodies (NAb).

Oct 15, 2024, 09:17 AM by

Oct 11, 2024, 01:00 AM by User Not Found

Bio-IT World | In early 2024, it was revealed that contract research and manufacturing organization WuXi Apptec had allegedly shared intellectual property with the Chinese government without their client’s consent. This breach of trust generated widespread concern and backlash, bringing renewed attention to the importance of proper data management and data sharing in the biotech and pharmaceutical industries.

Oct 10, 2024, 08:01 AM by

Oct 10, 2024, 08:01 AM by

Exothera has announced the appointment of a new CEO, Cédric Volanti.

Oct 9, 2024, 08:31 AM by

New Platform Reduces IND Submission Timelines for Small and Mid-Sized Pharma Companies.

Oct 8, 2024, 08:36 AM by

Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, reflecting an important milestone in Synexa’s ‘buy and build’ growth strategy. By combining the two complementary companies, the group can now offer an even more comprehensive range of services to an enlarged customer base, both in large and small molecule drug development, and ranging from pre-clinical work to phase III clinical studies.

Oct 8, 2024, 08:36 AM by

Oct 8, 2024, 08:18 AM by

Coronado Research announced the engagement of Rob Nichols to support the build-out of its clinical technology practice and advise the executive leadership team as they deliver the broader company vision.

Oct 8, 2024, 01:00 AM by User Not Found

Bio-IT World | In a data science paper published in June, a team of researchers at MIT presents GenSQL, a system to ease answering data science questions. They published the work in Proceedings of the ACM on Programming Languages. GenSQL is available open source in Clojure on GitHub.

Oct 3, 2024, 07:45 AM by

The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through commercialization.

Oct 3, 2024, 07:38 AM by

Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, today announced the launch of Concentriq® Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics.

Oct 3, 2024, 07:38 AM by

Oct 3, 2024, 01:00 AM by User Not Found

Bio-IT World | New work from Dr. Lachlan Jolly and the University of Adelaide’s Neurobiology Research Group is using cutting-edge RNA-based techniques to resolve genetic variants of uncertain significance (VUS) that can't be diagnosed through traditional methods. Many disease-causing genes do not express RNA in accessible tissues like blood or skin, leaving many patients without a clear diagnosis. To overcome this, the team is utilizing two innovative methods—transactivation and transdifferentiation.

Oct 2, 2024, 06:47 AM by

The accelerator seeks next-generation digital health solutions supporting preparedness and response to health security threats

Oct 2, 2024, 06:47 AM by

Oct 2, 2024, 06:47 AM by

This press release announces the partnership between Zymo Research and BluMaiden Biosciences to provide end-to-end clinical trial analytics and reporting services based on the human microbiome. We believe this development will be of significant interest to your audience, particularly those working in the pharmaceutical sector. The press release highlights how the new joint service will cover every stage of human microbiome analysis, including fit-for-purpose sample collection, nucleic acid purification, next-generation sequencing, sophisticated bioinformatics data analysis, and detailed clinical trial reporting. This service is designed to be applicable across entire trial cohorts and can be applied to a broad range of disease indications and intervention modalities, making it especially valuable for researchers and professionals in the pharma industry with the aim of enhancing therapeutic efficacy and commercial lifespan.

Oct 2, 2024, 06:47 AM by

The National Institute of Diabetes and Digestive and Kidney Diseases Awards Vaxess SBIR Phase I Funding to Test Company’s MIMIX Transdermal Patch Platform in Administering GLP-1 RA Therapies

Oct 2, 2024, 06:47 AM by

Sphere Fluidics has introduced Cyto-Mine Chroma – the second generation of its award-winning, flagship Cyto-Mine single cell analysis and isolation platform. With the upgrade to a four-color laser and detector system, Chroma offers enhanced capabilities to further maximise the efficiency and precision of single-cell functional analysis workflows. By accelerating the early selection of superior candidate cells, it supports project timelines to be reduced from months to weeks, and minimising effort and cost.